Cargando…
Clinical trials of investigational agents for IPF: a review of a Cochrane report
The magnitude of treatment effect can be assessed by a number of methods. One reliable method of collectively analysing data from randomised clinical trials is that used in Cochrane reviews. These systematic reviews identify and analyse the available evidence using the reliable method of meta-analys...
Autor principal: | Richeldi, Luca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643529/ https://www.ncbi.nlm.nih.gov/pubmed/23734867 http://dx.doi.org/10.1186/1465-9921-14-S1-S4 |
Ejemplares similares
-
Recommendations on treatment for IPF
por: Behr, Jürgen, et al.
Publicado: (2013) -
Differing severities of acute exacerbations of idiopathic pulmonary fibrosis (IPF): insights from the INPULSIS® trials
por: Kreuter, Michael, et al.
Publicado: (2019) -
IPF clinical trial design and endpoints
por: Nathan, Steven D., et al.
Publicado: (2014) -
Poor methodological reporting in lupus clinical trials found in Cochrane reviews
por: Goldsmith, CH
Publicado: (2012) -
Evaluation of the Cochrane tool for assessing risk of bias in randomized clinical trials: overview of published comments and analysis of user practice in Cochrane and non-Cochrane reviews
por: Jørgensen, Lars, et al.
Publicado: (2016)